1949Experimental Biology and MedicineRequires access

Antituberculous Activity and Toxicity of Lupulon for the Mouse.

Y.-C. Chin, Harold Anderson, Gemma Alderton, Justin Lewis

Open publisher page 37 citations

Abstract

Lupulon, a fat-soluble antibiotic derived from hops, has relatively low in vitro activity (1:40,000) as compared with other antituberculous agents. Despite this observation, lupulon (given orally or intramuscularly) was active against experimental mouse infections of M. tuberculosis. Following intramuscular administration, significantly lower numbers of acid-fast organisms occurred in lesions of treated animals. The approximate numbers relative to the control were: In the liver, 34 to 1; heart, 8 to 1; spleen, 4 to 1; and lungs, 4 to 1; but not in the kidneys. In orally treated animals the ratios were: Liver, 10 to 1; heart, 3 to 1; spleen, 10 to 1; lungs, 5 to 1, and kidneys, 2 to 1. The over-all difference was a reduction of approximately 4 to 1 by either route of administration.

About this research paper

What this paper is about

Lupulon, a fat-soluble antibiotic derived from hops, has relatively low in vitro activity (1:40,000) as compared with other antituberculous agents. Despite this observation, lupulon (given orally or intramuscularly) was active against experimental mouse infections of M. tuberculosis. Following intramuscular administration, significantly lower numbers of acid-fast organisms occurred in lesions of treated animals. The approximate numbers relative to the control were: In the liver, 34 to 1; heart, 8 to 1; spleen, 4 to 1; and lungs, 4 to 1; but not in the kidneys. In orally treated animals the ratios were: Liver, 10 to 1; heart, 3 to 1; spleen, 10 to 1; lungs, 5 to 1, and kidneys, 2 to 1. The over-all difference was a reduction of approximately 4 to 1 by either route of administration.

Why it matters

OpenAlex reports 37 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Lupulon, a fat-soluble antibiotic derived from hops, has relatively low in vitro activity (1:40,000) as compared with other antituberculous agents. Despite this observation, lupulon (given orally or intramuscularly) was active against experimental mouse infections of M. tuberculosis. Following intramuscular administration, significantly lower numbers of acid-fast organisms occurred in lesions of treated animals. The approximate numbers relative to the control were: In the liver, 34 to 1; heart, 8 to 1; spleen, 4 to 1; and lungs, 4 to 1; but not in the kidneys. In orally treated animals the ratios were: Liver, 10 to 1; heart, 3 to 1; spleen, 10 to 1; lungs, 5 to 1, and kidneys, 2 to 1. The over-all difference was a reduction of approximately 4 to 1 by either route of administration.

Key concepts: Spleen, Toxicity, Pharmacology, Antibiotics, In vitro, Oral administration, Medicine, Kidney

Related papers

Back to paper searchBrowse research topicsOriginal source
Antituberculous Activity and Toxicity of Lupulon for the Mouse. — Research Paper | ScholarLens